FDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder
Ultragenyx has secured its first approved gene therapy, with the FDA clearing its asset for an ultra-rare disease that can cause life-threatening blood sugar crashes. The FDA on Wednesday granted accelerated ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.